88 related articles for article (PubMed ID: 8508471)
1. Rapid determination of a new angiotensin-converting enzyme inhibitor, imidapril, and its active metabolite in human plasma by negative-ion desorption chemical ionization-tandem mass spectrometry (MS/MS).
Horimoto S; Mabuchi M; Banno K; Sato T
Chem Pharm Bull (Tokyo); 1993 Apr; 41(4):699-702. PubMed ID: 8508471
[TBL] [Abstract][Full Text] [Related]
2. Determination of imidapril and imidaprilat in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Mabuchi M; Kano Y; Fukuyama T; Kondo T
J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):145-53. PubMed ID: 10574200
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive determination of imidapril, a new angiotensin I-converting enzyme inhibitor, and its active metabolite in human plasma and urine using high-performance liquid chromatography with fluorescent labelling reagent.
Tagawa K; Hayashi K; Mizobe M; Noda K
J Chromatogr; 1993 Jul; 617(1):95-103. PubMed ID: 8376543
[TBL] [Abstract][Full Text] [Related]
4. Determination of three metabolites of a new angiotensin-converting enzyme inhibitor, imidapril, in plasma and urine by gas chromatography-mass spectrometry using multiple ion detection.
Matsuoka M; Horimoto S; Mabuchi M; Banno K
J Chromatogr; 1992 Oct; 581(1):65-73. PubMed ID: 1430009
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine.
Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K
J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752
[TBL] [Abstract][Full Text] [Related]
6. LC-MS determination and bioavailability study of imidapril hydrochloride after the oral administration of imidapril tablets in human volunteers.
Yun JH; Myung JH; Kim HJ; Lee S; Park JS; Kim W; Lee EH; Moon CJ; Hwang SJ
Arch Pharm Res; 2005 Apr; 28(4):463-8. PubMed ID: 15918521
[TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
Yamanaka K; Takehara N; Murata K; Banno K; Sato T
J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331
[TBL] [Abstract][Full Text] [Related]
8. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
[TBL] [Abstract][Full Text] [Related]
9. Trace analysis of quinapril and its active metabolite, quinaprilat, in human plasma and urine by gas chromatography-negative-ion chemical ionization mass spectrometry.
Goto N; Kamata T; Ikegami K
J Chromatogr; 1992 Jul; 578(2):195-201. PubMed ID: 1400797
[TBL] [Abstract][Full Text] [Related]
10. A saturable tissue-angiotensin I converting enzyme (ACE) binding model for the pharmacokinetic analysis of imidapril, a new ACE inhibitor, and its active metabolite in human.
Tagawa K; Mizobe M; Noda K
Biol Pharm Bull; 1995 Jan; 18(1):64-9. PubMed ID: 7735253
[TBL] [Abstract][Full Text] [Related]
11. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 5th communication: isolation and identification of metabolites of imidapril in rats, dogs, and monkeys.
Yamada Y; Ohashi R; Sugawara Y; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):490-8. PubMed ID: 1642672
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic study of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor, in spontaneously hypertensive rats.
Yamanaka K; Takehara N; Murata K; Banno K; Sato T
J Pharm Biomed Anal; 1997 Aug; 15(12):1851-9. PubMed ID: 9278890
[TBL] [Abstract][Full Text] [Related]
13. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 7th communication: in vitro metabolism.
Yamada Y; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):507-12. PubMed ID: 1642674
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
Harder S; Thürmann PA
Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function.
Hoogkamer JF; Kleinbloesem CH; Nokhodian A; Ouwerkerk MJ; Lankhaar G; Ungethüm W; Kirch W
Eur J Clin Pharmacol; 1997; 51(6):489-91. PubMed ID: 9112065
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of moexipril and moexiprilat, its active metabolite, in human plasma by gas chromatography-negative-ion chemical ionization mass spectrometry.
Hammes W; Hammes B; Büchsler U; Paar F; Bökens H
J Chromatogr B Biomed Appl; 1995 Aug; 670(1):81-9. PubMed ID: 7493088
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography-mass spectrometry method for determination of ramipril and its active metabolite ramiprilat in human plasma.
Zhu Z; Vachareau A; Neirinck L
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):297-306. PubMed ID: 12361743
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma.
Cui S; Feng F; Ma M; Liu H; Chen Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):143-51. PubMed ID: 17482898
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry.
Leis HJ; Fauler G; Raspotnig G; Windischhofer W
Rapid Commun Mass Spectrom; 1998; 12(21):1591-4. PubMed ID: 9807834
[TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
